BALYASNY ASSET MANAGEMENT L.P. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$340,067
+728.6%
16,318
+533.0%
0.00%
Q4 2022$41,042
-71.9%
2,578
-75.2%
0.00%
Q2 2022$146,000
-92.7%
10,390
-87.9%
0.00%
-100.0%
Q4 2021$2,000,000
-6.6%
85,687
-33.6%
0.01%
-22.2%
Q3 2021$2,142,000
-76.2%
128,978
-40.8%
0.01%
-86.4%
Q3 2020$8,987,000
+2277.5%
217,864
+2696.0%
0.07%
+2100.0%
Q2 2020$378,000
-70.4%
7,792
-90.1%
0.00%
-66.7%
Q4 2018$1,275,000
-95.3%
78,845
-94.0%
0.01%
-92.6%
Q3 2018$26,907,000
+29.7%
1,311,076
-3.5%
0.12%
+29.8%
Q2 2018$20,749,000
+27.5%
1,358,793
+87.5%
0.09%
+38.2%
Q1 2018$16,280,000
+51.0%
724,500
+102.4%
0.07%
+100.0%
Q4 2017$10,778,000
+32.5%
357,958
+22.7%
0.03%
+3.0%
Q2 2017$8,137,000
-34.8%
291,745
-32.6%
0.03%
-50.7%
Q4 2016$12,479,000
+4356.8%
432,691
+4226.9%
0.07%
+3250.0%
Q1 2016$280,00010,0000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 432,317$11,154,0004.70%
Baker Brothers Advisors 41,910,704$1,081,296,0004.69%
Palo Alto Investors LP 2,337,877$60,317,0003.44%
Birchview Capital, LP 177,000$4,567,0002.71%
Longitude (Cayman) Ltd. 188,000$4,850,0001.86%
GREAT POINT PARTNERS LLC 311,217$8,029,0001.66%
Avoro Capital Advisors LLC 2,500,000$64,500,0001.11%
PFM Health Sciences, LP 1,302,129$33,595,0001.03%
HealthCor Management, L.P. 900,490$23,233,0000.82%
Eversept Partners, LP 420,000$10,836,0000.82%
View complete list of ACADIA PHARMACEUTICALS INC shareholders